Skip to main content

Table 1 Demographic and clinical data of extracorporeal membrane oxygenation patients (n = 49) between 1999 and 2001

From: Surfactant application during extracorporeal membrane oxygenation improves lung volume and pulmonary mechanics in children with respiratory failure

 

Group S (surfactant; n = 7)

Group C (control; n = 6)

Remaining ECMO patients (n = 36)

Gender (male/female)

5/2

6/0

25/11

Age (months)a

5.1 ± 8.5

7.5 ± 9.7

11 ± 25.1

Weight (kg)a

5.1 ± 3.5

6.0 ± 4.1

6.3 ± 7.3

Diagnosis (ARDS/CHD)a

5/2 (71%/29%)

4/2 (67%/33%)

8/19 (22%/53%)

ECMO (days)

9 ± 7.9

9 ± 6.2

6.7 ± 4.9

ECMO (hours)

217.4 ± 198

214.8 ± 152

154.2 ± 117.2

PICU (days)

24.5 ± 19.2

19.5 ± 4.3

18.3 ± 14.1

Ventilator (days)

23.5 ± 17.7

17.5 ± 5.1

16.2 ± 13.4

Hospital (days)

29.5 ± 18.3

23.2 ± 8.8

22.3 ± 16

Survival (y/n)

2/5

3/3

16/20 (44%/56%)

  1. aMatching variables. Data are presented as mean ± standard error of the mean. There were no significant differences between the two groups regarding all demographic data. ARDS, acute respiratory distress syndrome; CHD, congenital heart disease; ECMO, extracorporeal membrane oxygenation; PICU, pediatric intensive care unit.
Back to article page

Critical Care

ISSN: 1364-8535